Recurrent hepatitis C virus after transplant and the importance of plasma cells on biopsy

Area of Science:

• Hepatology
• Transplantation Immunology
• Virology

Background:

• Hepatitis C virus (HCV) is a primary reason for liver transplants in the US.
• HCV recurrence post-transplant is universal, but fibrosis progression and graft failure rates vary.
• Plasma cell hepatitis, a histological finding, correlates with adverse graft and patient outcomes.

Purpose of the Study:

• To highlight plasma cell hepatitis as a significant post-transplant complication.
• To discuss the poorly understood pathogenic mechanisms of plasma cell hepatitis.
• To review potential management strategies for plasma cell hepatitis.

Main Methods:

• Review of existing literature on plasma cell hepatitis in liver transplant recipients.
• Analysis of data linking histologic findings to patient and graft outcomes.
• Commentary on immune-mediated graft dysfunction in the context of interferon-based therapy.

Main Results:

• Plasma cell hepatitis is associated with poor graft and patient outcomes.
• Pathogenesis likely involves both HCV and the host immune system.
• Interferon-based therapies may be associated with immune-mediated graft dysfunction, including plasma cell hepatitis.

Conclusions:

• Plasma cell hepatitis is an under-recognized complication of liver transplantation for HCV.
• Further research is needed to elucidate the exact pathogenic mechanisms.
• Identifying effective management strategies is crucial for improving outcomes.